CIGNA's Limited Brand Coverage In Part D Gap Emphasizes Challenges
Executive Summary
After several years of no national Medicare Part D prescription drug plan sponsors offering any kind of brand drug coverage in the donut hole, CIGNA's "Medicare Rx Plan Three" product offering in 2010 will give seniors suffering from hypothyroidism that option
You may also be interested in...
CMS Budgets $110 Million For Broad Internal IT System Overhaul
CMS is planning a broad initiative aimed at making the wealth of data it collects from Medicare and Medicaid beneficiaries more accessible and usable for analysis and is asking Congress for $110 million to accomplish it
CMS Budgets $110 Million For Broad Internal IT System Overhaul
CMS is planning a broad initiative aimed at making the wealth of data it collects from Medicare and Medicaid beneficiaries more accessible and usable for analysis and is asking Congress for $110 million to accomplish it
Getting To $80 Bil.: PhRMA Expects Mix Of Rebates And Fees In Finance Bill
The Pharmaceutical Research and Manufacturers of America is expecting to make good on its pledge to contribute $80 billion to health care reform through a combination of drug rebates and fees, in addition to savings from follow-on biologics and the previously announced 50 percent discount on drugs used in the Medicare Part D donut hole